Why did Moderna stock drop today?
$Moderna(MRNA.US$ shares are falling today as investors react to a delayed timeline for the company COVID-19 shot targeted at adolescents.
On Sunday, Massachusetts-based biotech said that the FDA is unlikely to complete its review on the vaccine for use in those aged 12 – 17 years.
Until that evaluation is complete, the company said it would not file an FDA submission seeking its clearance for use in the 6 – 11-year age group.
Jeff Zients, President Biden’s Covid-19 response coordinator, and CDC Director, Rochelle Walensky, brushed off its impact on the anticipated rollout of $Pfizer(PFE.US$ / $BioNTech(BNTX.US$ COVID-19 shot for kids aged 5 – 11 years.
“There’s plenty of supply of Pfizer vaccine, and we look forward to parents having the opportunity to vaccinate their kids,” Bloomberg quoted Zients as saying.
However, the twin setbacks have hurt Moderna, with shares recording the biggest intraday decline since Oct. 22.
Yet, as the following graph indicates, the stock has added over 200% since the start of the year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Susan Bertolino : Is this situation buying or selling?
Teddy Willson : This benefits BNTX. But that somehow also found a way to drop smh
baby boomers : How about redirecting money to imvestors rather excessively enriching senior company executives with tons of stock options?
Harper lee : How many fat kids with diabetes died from Covid over the past 18 months in the United States? Only 3
So why all these covid vaccines approvals?
Wyatt lincoln Harper lee: LOL.....WHERE is the proof that only THREE overweight children with diabetes, died from the coronavirus? Do you have a link to reputable news or government or healthcare source?
Spider-Man to moon Wyatt lincoln: Actually 3 was too high. There's been no reported deaths of children who tested positive for Covid.
Children and COVID-19: State-Level Data Report